|
GAB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3626999999915E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.393600E-04 |
| Normal-vs-Stage2 |
1.224920E-03 |
| Normal-vs-Stage3 |
9.60949999999627E-05 |
| Normal-vs-Stage4 |
5.16670000005881E-07 |
| Stage1-vs-Stage2 |
1.961630E-01 |
| Stage1-vs-Stage3 |
1.536360E-01 |
| Stage1-vs-Stage4 |
1.335130E-03 |
| Stage2-vs-Stage3 |
8.147600E-01 |
| Stage2-vs-Stage4 |
2.897600E-01 |
| Stage3-vs-Stage4 |
1.100830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6478000000062E-05 |
| Normal-vs-AfricanAmerican |
1.101830E-02 |
| Normal-vs-Asian |
3.609500E-02 |
| Caucasian-vs-AfricanAmerican |
9.087000E-01 |
| Caucasian-vs-Asian |
2.289600E-01 |
| AfricanAmerican-vs-Asian |
3.926200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.55069999957713E-07 |
| Normal-vs-Female |
3.199600E-04 |
| Male-vs-Female |
2.331800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.340400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.041050E-04 |
| Normal-vs-Age(61-80Yrs) |
2.57309999973643E-07 |
| Normal-vs-Age(81-100Yrs) |
7.181700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.067820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.963000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.157440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.159500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.006400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.343400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.239800E-02 |
| Classical-VS-Follicular |
7.587200E-04 |
| Classical-VS-Other |
1.903410E-01 |
| Classical-VS-Normal |
2.620200E-03 |
| Tall-VS-Follicular |
5.136400E-01 |
| Tall-VS-Other |
5.330000E-01 |
| Tall-VS-Normal |
9.64789999999827E-05 |
| Follicular-VS-Other |
8.394200E-01 |
| Follicular-VS-Normal |
6.94100000031561E-07 |
| Other-VS-Normal |
2.026400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46449999999898E-05 |
| Normal-vs-N1 |
1.559370E-04 |
| N0-vs-N1 |
7.358600E-01 |
|
|
